Just a guess at joining the dots so def not concrete, just a theory: We currently don't have a great deal of cash, so we cant really ramp up production of the patches, and as has been stated, they are going to inhouse manufacture to reduce costs and increase profits starting Nov 2022. If they sign with a major retailer in USA or Europe, they still need to find the $$s to manufacture, depending on the terms of trade. So if we manufacture now loads of patches for USA/Europe, we make little profit. So maybe the plan now is to do a soft launch in Australia, which is a smaller market, iron out any issues, get the machines inhouse, and then gear up for the USA/Europe in 2023.
Any thoughts?
- Forums
- ASX - By Stock
- WFL
- Ann: Swisswell Knee Patch Registered as a Medical Device
Ann: Swisswell Knee Patch Registered as a Medical Device, page-11
-
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable